CEREBRUS LTD has a total of 61 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are PFIZER PRODUCTS INC SA ORGANIZ, HARBIN GLORIA PHARMACEUTICALS CO LTD and REVOTAR BIOPHARMACEUTICALS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 51 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 2 | |
#4 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Fletcher Allan | 4 |
#2 | Adams David Reginald | 3 |
#3 | Mansell Howard Langham | 3 |
#4 | Monck Nathaniel Julius | 3 |
#5 | Cliffe Ian Anthony | 3 |
#6 | Bodkin Corinna Dagmar | 2 |
#7 | Bebbington David | 2 |
#8 | Gaur Suneel | 2 |
#9 | Weiss Scott Murray | 2 |
#10 | Knutsen Lars Jacob Stray | 2 |
Publication | Filing date | Title |
---|---|---|
GB9918965D0 | Chemical compounds xxi | |
GB9918962D0 | Chemical compounds xxii | |
GB9917385D0 | Chemical compounds-I | |
GB9917384D0 | Chemical compounds-III | |
GB9917386D0 | Chemical compounds-II | |
GB9915437D0 | Chemical compounds III | |
GB9909496D0 | Chemical compounds II | |
GB9909495D0 | Chemical compounds III | |
GB9909497D0 | Chemical compounds I | |
GB9902047D0 | Chemical compounds XI | |
GB9901691D0 | Chemical compounds | |
WO9937613A1 | Azetidinecarboxamide derivatives for treating cns disorders | |
GB9826356D0 | Chemical compounds 111 | |
GB9826358D0 | Chemical compounds I | |
GB9826357D0 | Chemical compounds 111 | |
AU1251499A | (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders | |
GB9825638D0 | Chemical compounds IX | |
GB9823832D0 | Chemical compounds | |
GB9823828D0 | Chemical compounds | |
GB9823830D0 | Chemical compounds |